Table 1.
Characteristics N = 398 822
| N (%) | |
|---|---|
| Sex | |
| Women | 162 506 (40.8) |
| Men | 236 316 (59.3) |
| Age at death (years) | |
| <60 | 77 469 (19.4) |
| [60;70] | 102 760 (25.8) |
| [70;80] | 101 295 (25.4) |
| ≥80 | 117 298 (29.4) |
| Year of death | |
| 2013 | 96 868 (24.3) |
| 2014 | 98 948 (24.8) |
| 2015 | 100 383 (25.2) |
| 2016 | 102 623 (25.7) |
| Last hospitalization stay duration | |
| ≥7 d | 242 071 (60.7) |
| ≥31 d | 47 952 (12.0) |
| Hospital type | |
| Non specializeda | 300 347 (75.3) |
| Specializeda | 98 475 (24.7) |
| Cancer localization | |
| Digestive | 134 934 (33.8) |
| Pancreas | 29 660 (7.4) |
| Esophageal | 23 340 (5.9) |
| Others | 81 934 (20.5) |
| Lung/thoracic | 95 068 (23.8) |
| Genital (male and female) | 44 368 (11.1) |
| Breast | 34 193 (8.6) |
| Hematologic | 32 320 (8.1) |
| Urinary tract | 29 099 (7.3) |
| Head and neck | 18 635 (4.7) |
| Nervous system | 11 960 (3.0) |
| Othersb | 17 289 (4.3) |
| Unknown primary site | 8170 (2.1) |
| Comorbidities (Charlson)c | |
| 0 | 160 316 (40.2) |
| 1 or 2 | 141 498 (35.5) |
| 3 or 4 | 64 112 (16.1) |
| ≥5 | 32 896 (8.3) |
| Diabete without complication | 72 634 (18.2) |
| Congestive heart failure | 67 122 (16.8) |
| Chronic pulm. disease | 54 515 (13.7) |
| Renal disease | 44 671 (11.2) |
| Malnutrition | |
| The last 7 d | 119 296 (29.9) |
| The last 31 d | 147 775 (37.1) |
| Chemotherapy use | |
| The last 7 d | 31 926 (8.0) |
| The last 31 d | 85 580 (21.5) |
| Palliative care use | |
| The last 7 d | 297 012 (74.5) |
| The last 31 d | 301 424 (75.6) |
a
Specialized centers include cancer units of an university hospital and units of a cancer hospital, non‐specialized centers include all the other cases.
b
Others: skin (2.52%), bone (1.10%), endocrine glands (0.58%), eye (0.14%).
c
Charlson modified score (excluding malignancies/metastasis).